
This eBook, titled "Advancing Drug Discovery with Organoid Imaging Workflows" (2nd Edition) published by Leica Microsystems, focuses on the role of advanced imaging technologies and workflows for complex in vitro models (CIVMs), specifically organoids and spheroids.
Key takeaways
1. Regulatory Shifts Drive 3D Cell Model Adoption
Driven by initiatives such as the FDA Modernization Act 2.0, preclinical research has shifted more toward physiologically relevant, human-derived 3D cell systems like organoids, spheroids, assembloids, and organ-on-a-chip technologies.
2. Core Challenges in Imaging 3D Organoid Models
3. Specialized Microscopy Modalities Serve Distinct Stages
4. Real-World Case Studies
5. AI-Driven Image Analysis Accelerates Insights
The integration of AI software, such as Leica Microsystems' Aivia platform, leverages state-of-the-art, AI-first software architecture for 2D-5D image visualization, analysis, and interpretation – for reliable processing and reconstruction of highly complex images in just minutes.
Download the eBook to learn how different imaging approaches can add unique value to 3D cell model characterization for drug research.

DOWNLOAD THIS EBOOK TO LEARN MORE

Create an account now for exclusive benefits, personalized recommendations, and seamless order tracking. Elevate your lab experience today!